Furthermore, dissociating the cis PD-L1:CD80 heterodimers with the intention of retaining DCs in peripheral tissues is a promising therapeutic avenue in disease contexts where DC-driven downstream adaptive immune responses are unfavorable, such as in the context of transplantation and autoimmune disease, like psoriasis (76, 77). This evidence concerns the gene CD274 and autoimmune disease.